HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014 - 2024

News provided by

Sep 23, 2014, 01:24 ET

DUBLIN, Sept. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014 - 2024" report to their offering.

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

The HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014-2024' report provides an extensive study of the rapidly growing manufacturing market of HPAPIs and cytotoxic drugs. Due to their numerous advantages and increased applications in treatment of cancer and other disorders, HPAPIs and cytotoxics have emerged as one of the key focus areas of researchers across the globe. When compared to conventional therapeutic products, these compounds offer multiple advantages. The focus of this report is primarily to understand the likely future evolution of contract manufacturing of HPAPIs and cytotoxics over the next decade.

The report covers various aspects such as analysis of CMOs involved in HPAPI/Cytotoxics manufacturing, pharmaceutical companies with in-house capabilities, regulatory guidelines, key drivers and upcoming opportunities for various stakeholders. Though a few pharmaceutical companies have in-house capabilities, a sizeable proportion of this market is covered by contract manufacturing.

The future growth in the market will primarily be driven by the rapidly expanding market for oncology drugs; majority of the high potency and cytotoxic drugs are being developed for treatment of cancer. With evolving clinical research, use of HPAPIs and cytotoxics in other therapeutic areas such as glaucoma, hormonal imbalances and respiratory disorders have also been identified.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET OVERVIEW

5. HPAPI MANUFACTURING MARKET

6. CYTOTOXIC DRUGS MANUFACTURING MARKET

7. CASE IN POINT: THE ONE STOP SHOPS'

8. MARKET SIZE AND FORECAST

9. PROFILES OF LEADING COMPANIES

10. RECENT DEVELOPMENTS

11. SWOT ANALYSIS

12. EMERGING FOCUS: CONTRACT MANUFACTURING OF ADCs

13. INTERVIEW TRANSCRIPTS

14. CONCLUSION

15. APPENDIX I: Tabulated Data

16. APPENDIX II: List of Companies

Companies Mentioned: